CompaniesCyDex Pharmaceuticals

CyDex Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

24

By Phase

PHASE2: 1NA: 1

By Status

WITHDRAWN: 1COMPLETED: 1

Recent Trials

NCT04627831Collaborator
Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography
PHASE2Withdrawn
Started: Jan 31, 2022 · Completed: Apr 30, 2023
NCT03869983Lead Sponsor
Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection and Omnipaque™ Injection
NACompleted
24 participants
Started: Apr 12, 2019 · Completed: Jun 15, 2019
Funding History (3)
S-1/A
Jun 18, 2008
Filing
S-1/A
May 13, 2008
Filing
S-1
Mar 12, 2008
Filing
Related Companies
Ligand Jan 2011----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired